TY  - JOUR
A1  - Deola, Sara
A1  - Guerrouahen, Bella S.
A1  - Sidahmed, Heba
A1  - Al‑Mohannadi, Anjud
A1  - Elnaggar, Muhammad
A1  - Elsadig, Ramaz
A1  - Abdelalim, Essam M.
A1  - Petrovski, Goran
A1  - Gadina, Massimo
A1  - Thrasher, Adrian
A1  - Wels, Winfried
A1  - Hunger, Stephen P.
A1  - Wang, Ena
A1  - Marincola, Francesco M.
A1  - Maccalli, Cristina
A1  - Cugno, Chiara
T1  - Tailoring cells for clinical needs : meeting report from the advanced therapy in healthcare symposium (October 28–29 2017, Doha, Qatar)
T2  - Journal of translational medicine
N2  - New technologies and therapies designed to facilitate development of personalized treatments are rapidly emerging in the field of biomedicine. Strikingly, the goal of personalized medicine refined the concept of therapy by developing cell-based therapies, the so-called “living drugs”. Breakthrough advancements were achieved in this regard in the fields of gene therapy, cell therapy, tissue-engineered products and advanced therapeutic techniques. The Advanced Therapies in Healthcare symposium, organized by the Clinical Research Center Department of Sidra Medicine, in Doha, Qatar (October 2017), brought together world-renowned experts from the fields of oncology, hematology, immunology, inflammation, autoimmune disorders, and stem cells to offer a comprehensive picture of the status of worldwide advanced therapies in both pre-clinical and clinical development, providing insights to the research phase, clinical data and regulatory aspects of these therapies. Highlights of the meeting are provided in this meeting report.
KW  - Personalized medicine
KW  - Cell therapy
KW  - Gene therapy
KW  - Stem cells
KW  - Autoimmunity
KW  - Oncology
KW  - Hematology
KW  - Preclinical
KW  - Clinical trials
Y1  - 2018
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/47695
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-476953
SN  - 1479-5876
N1  - Open Access: This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
VL  - 16
IS  - 1, Art. 276
SP  - 1
EP  - 15
PB  - BioMed Central
CY  - London
ER  -